# Arrowhead Research Corporation (ARWR) — Stock CV

Arrowhead Research Corporation is a $8.86B healthcare company. Revenue grew 16.8% over the last year, it currently loses money, and it holds more cash than debt.

> Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction.

## Identity

- **Ticker**: ARWR
- **Sector**: Healthcare
- **Industry**: Pharmaceutical Preparations
- **Headquarters**: PASADENA, CA
- **Employees**: 711
- **Website**: https://www.arrowheadpharma.com
- **Market cap**: $8.86B
- **Last price**: $62.75
- **Financial profile**: Solid

## Vitals (TTM)

- **Revenue**: $669M
- **Net income**: -$320M
- **Free cash flow**: -$75.1M
- **Net cash**: $478M
- **Revenue growth (YoY)**: 16.8%

## Skills (profile scores, 0–100)

| Pillar | Score |
|---|---|
| Valuation | 35 |
| Growth | 25 |
| Profitability | 0 |
| Health | 71 |
| Quality | 15 |
| Moat | 0 |

## Qualifications (beginner checklist) — 5 of 9 passed

- [x] Revenue growing — +16.8% YoY
- [ ] Profitable — -$320M TTM
- [x] Profit growing — +99.7% YoY
- [ ] Generates cash — -$75.1M TTM
- [x] Debt under control — more cash than debt
- [x] Established company — $8.86B market cap
- [ ] Not printing shares — +32.8% shares over ~5y
- [ ] Proven track record — 1/10 profitable years
- [x] Financially stable — Altman Z 2.5 — grey

## Experience (career milestones)

- **FY2024** — Became debt-free: cash now exceeds total debt
- **FY2019** — Turned profitable: $68.0M net income after a loss year
- **FY2019** — Best year on record: $68.0M net income
- **Oct 31, 2018** — Arrowhead Pharmaceuticals Inc. closed on a $3.7 billion license and collaboration agreement…
- **2015** — The company substantially expanded its intellectual property holdings through complete acquisition of the…

## Strengths

- High gross margin (100.0%)
- Revenue growing 16.8% year over year
- Net cash position after subtracting debt from cash

## Watch-outs

- Not profitable — 47.8% net margin
- Negative free cash flow (-$75.1M)
- Thin interest coverage (2.0×)
- Loss-making in 9 of the recent years

## Track record

| Year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| FY2021 | $138M | -$141M | $148M |
| FY2022 | $243M | -$176M | -$189M |
| FY2023 | $241M | -$205M | -$331M |
| FY2024 | $3.55M | -$599M | -$604M |
| FY2025 | $829M | -$1.63M | $157M |

---

Source: https://stockcv.com/ARWR — derived from company filings; may be delayed or incomplete. Information, not investment advice.